Literature DB >> 16842399

Patients' knowledge of adverse reactions to current medications.

Garret Cullen1, Emer Kelly, Frank E Murray.   

Abstract

AIMS: Adverse drug reactions (ADRs) account for 3.2-7% of acute hospital admissions. The aim of this study was to assess prospectively knowledge of ADRs in patients admitted through the emergency department of a teaching hospital.
METHODS: Three hundred and ninety-nine patients were admitted on acute medical call during study periods in September 2002 and May 2003. One hundred gave their perception of the risk of ADRs using visual analogue scales, where 0 indicates minimum and 10 maximum risk. The medications studied were warfarin, proton pump inhibitors (PPIs), corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin. Responses are compared against a medical control group.
RESULTS: Corticosteroids were ranked most dangerous by patients (median score, 25th-75th centiles: 5.4, 2.9-8.7). Medical staff ranked NSAIDs as highest risk (6.2, 4.0-7.5). Patients identified NSAIDs as low risk (2.1, 0.7-4.9), perceiving the risk of cardiac arrhythmias and disturbance in liver biochemistry to be equivalent to risk of upper gastrointestinal ulceration and bleeding. Risk of haemorrhage was ranked as the most common ADR for warfarin by patients (8.6, 3.3-9.5) and medical staff (8.8, 7.6-9.3).
CONCLUSIONS: Patients underrate the risk of ADRs of their medications. While there is a good level of knowledge of ADRs amongst warfarin and aspirin users, there is a clear lack of knowledge regarding the risk of upper GI bleeding in NSAID users. Increased education may reduce the incidence of ADRs but it is more likely that it will serve to meet increasing patient expectations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842399      PMCID: PMC1885086          DOI: 10.1111/j.1365-2125.2006.02642.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.

Authors:  P Pouyanne; F Haramburu; J L Imbs; B Bégaud
Journal:  BMJ       Date:  2000-04-15

2.  Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.

Authors:  V Bongard; S Ménard-Taché; H Bagheri; K Kabiri; M Lapeyre-Mestre; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

3.  How much information about adverse effects of medication do patients want from physicians?

Authors:  D K Ziegler; M C Mosier; M Buenaver; K Okuyemi
Journal:  Arch Intern Med       Date:  2001-03-12

Review 4.  Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.

Authors:  M R Griffin
Journal:  Am J Med       Date:  1998-03-30       Impact factor: 4.965

5.  Rate, type, and cost of adverse drug reactions in emergency department admissions.

Authors:  J -B. Wasserfallen; F Livio; T Buclin; L Tillet; B Yersin; J Biollaz
Journal:  Eur J Intern Med       Date:  2001-09       Impact factor: 4.487

6.  Clinical and economic impact of adverse drug reactions in hospitalized patients.

Authors:  D C Suh; B S Woodall; S K Shin; E R Hermes-De Santis
Journal:  Ann Pharmacother       Date:  2000-12       Impact factor: 3.154

7.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D C Classen; S L Pestotnik; R S Evans; J F Lloyd; J P Burke
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

  7 in total
  24 in total

1.  Physicians' perceptions of the definition of major bleeding in major orthopedic surgery: results of an international survey.

Authors:  Enrique Ginzburg; Franck Dujardin
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

2.  Risk perception in drug therapy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

3.  Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.

Authors:  G Durrieu; C Hurault; V Bongard; C Damase-Michel; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2007-03-22       Impact factor: 4.335

4.  Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand.

Authors:  Pacharaporn Phueanpinit; Juraporn Pongwecharak; Janet Krska; Narumol Jarernsiripornkul
Journal:  Int J Clin Pharm       Date:  2016-07-29

5.  Knowledge, Beliefs and Behaviours Regarding the Adverse Effects of Medicines in an Omani Population: Cross-sectional survey.

Authors:  Jimmy Jose; Beena Jimmy; Moza N S Al-Mamari; Thuraiya S N Al-Hadrami; Halima M Al-Zadjali
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

6.  Non-steroidal anti-inflammatory drug prescriptions in hospital inpatients: are we assessing the risks?

Authors:  J Kitchen; D Kane
Journal:  Ir J Med Sci       Date:  2010-05-30       Impact factor: 1.568

7.  What affects anticoagulation control in patients taking warfarin?

Authors:  Lindsay Smith; Edzard Ernst; Paul Ewings; Jeffrey Allen; Caroline Smith; Catherine Quinlan
Journal:  Br J Gen Pract       Date:  2009-07-15       Impact factor: 5.386

8.  Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.

Authors:  Pacharaporn Phueanpinit; Narumol Jarernsiripornkul; Juraporn Pongwecharak; Janet Krska
Journal:  Int J Clin Pharm       Date:  2014-10-07

9.  Insights from Monitoring Aspirin Adherence: A Medication Adherence Cascade Tool.

Authors:  Heather L Wheat; Elliane Irani; Joel Hughes; Richard Josephson; Mary A Dolansky
Journal:  Patient Prefer Adherence       Date:  2021-07-26       Impact factor: 2.711

10.  Knowledge and attitudes of HIV-infected patients on antiretroviral therapy regarding adverse drug reactions (ADRs) in selected hospitals in Nigeria.

Authors:  Kenneth Anene Agu; Azuka Cyriacus Oparah; Uche M Ochei
Journal:  Perspect Clin Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.